Tekla Capital Management LLC Deciphera Pharmaceuticals, Inc. Transaction History

Tekla Capital Management LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$26.46 - $37.15 $8.14 Million - $11.4 Million	-307,703 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$40.39 - $56.73 $9.95 Million - $14 Million	246,333 Added 401.39%	307,703 $13.8 Million
Q4 2019 Feb 13, 2020	BUY	$31.7 - $69.93 $1.95 Million - $4.29 Million	61,370 New	61,370 $3.82 Million

343K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Tekla Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Tekla Capital Management LLC with notifications on news.